Evaluating the effect of Garlic on dialysis patients

Evaluation of Garlic tablet effects on Hemodialysis patients Inflammatory factors.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200831048562N1

Enrollment

Registered

2021-03-15

Start date

2021-03-10

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients. Chronic kidney disease (CKD)

Interventions

Intervention 1: Intervention group: Group A is given garlic tablets twice a day for two months. Intervention 2: Control group: Group B placebo (without color and taste) is given twice a day for two mo

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All ESRD patients who need hemodialysis (at least six months before dialysis starts)

Exclusion criteria

Exclusion criteria: Allergic to garlic patients Corticosteroids, Anticoagulants, and Statins using records Underlying autoimmune disease records on patients

Design outcomes

Primary

Measure	Time frame
CRP. Timepoint: At the beginning of the study and two months after intervention. Method of measurement: serum sample.;ESR. Timepoint: At the beginning of the study and two months after intervention. Method of measurement: serum sample.;IL6. Timepoint: At the beginning of the study and two months after intervention. Method of measurement: serum sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh khanzadeh

Qazvin University of Medical Sciences

F.khanzadeh7@gmail.com+98 28 3368 4264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026